Gliclazide MR Tablets are a modified-release formulation containing 30mg of the active substance gliclazide. This product is manufactured by Lekpharm in Belarus and comes in a pack of 30 tablets (3 blister packs of 10 tablets each).
Gliclazide is a sulfonylurea used to help manage blood sugar levels in adults with type 2 diabetes. The modified-release design allows for gradual delivery of the medication over time, supporting consistent glucose control as part of a comprehensive diabetes care plan.
Modified-release tablets are designed to release the active ingredient gradually over time, which can help maintain more stable blood levels of the medication.
The pack contains 30 tablets, divided into 3 blister packs of 10 tablets each.
This product is manufactured by Lekpharm (OOO Lekfarm) in Belarus.
$19
In stock โ ready to ship